skip to Main Content

Blue Shield California March 2018 Medical Policy Updates

Click here to view the Blue Shield California Medical Policy Updates »

March 2018 Medical Policy Updates:

  • Accelerated Breast Irradiation and Brachytherapy Boost After Breast-Conserving Surgery for Early-Stage Breast Cancer
  • Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast
  • Adoptive Immunotherapy
  • Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
  • Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
  • Artificial Pancreas Device Systems
  • Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non‒Orthopedic Conditions
  • Bioimpedance Devices for Detection and Management of Lymphedema
  • Cognitive Rehabilitation
  • Dermatologic Applications of Photodynamic Therapy
  • DNA-Based Testing for Adolescent Idiopathic Scoliosis
  • Drug Testing in Pain Management and Substance Abuse Treatment
  • Electrostimulation and Electromagnetic Therapy for Treating Wounds
  • Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
  • Genetic Testing for Alpha1-Antitrypsin Deficiency
  • Genetic Testing for Cardiac Ion Channelopathies
  • Genetic Testing for FLT3, NPM1, and CEBPA Variants in Cytogenetically Normal Acute Myeloid Leukemia
  • Genetic Testing for FMR1 Variants (Including Fragile X Syndrome)
  • Genetic Testing for Neurofibromatosis
  • Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathies
  • Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
  • Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
  • Hematopoietic Cell Transplantation for Autoimmune Diseases
  • Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and Ependymoma
  • Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
  • Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
  • Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas
  • Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome
  • Lymphedema Surgery
  • Molecular Markers in Fine Needle Aspirates of the Thyroid
  • Noncontact Ultrasound Treatment for Wounds
  • Oncologic Applications of Photodynamic Therapy, Including Barrett Esophagus
  • Personalized Breast Cancer Screening Clinical Trial
  • Placental and Umbilical Cord Blood as a Source of Stem Cells


Click here to view the Blue Shield California Medical Policy Updates »


Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top